ClinicalTrials.gov
public full text
Public Domain
Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance
This study is an open-label, single-arm, phase I study of irinotecan liposome injection in patients with advanced breast cancer. The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics of irinotecan liposome injection in patients with advanced breast cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors#1340059
- Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors#811056
- Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer#160375
- Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.#900705
- Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer#902377
Record · ID 1378386
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive